In vivo requirement of the small subunit of U2AF for recognition of a weak 3′ splice site

被引:49
作者
Pacheco, Teresa R. [1 ]
Coelho, Miguel B. [1 ]
Desterro, Joana M. P. [1 ]
Mollet, Ines [1 ]
Carmo-Fonseca, Maria [1 ]
机构
[1] Univ Lisbon, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal
关键词
D O I
10.1128/MCB.00350-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The U2 snRNP auxiliary factor (U2AF) is an essential splicing factor composed of two subunits, a large, 65-kDa subunit (U2AF(65)) and a small subunit, U2AF(35). U2AF(65) binds to the polypyrimidine tract upstream from the 3' splice site and promotes U2 snRNP binding to the pre-mRNA. Based on in vitro studies, it has been proposed that U2AF(35) plays a role in assisting U2AF(65) recruitment to nonconsensus polypyrimidine tracts. Here we have analyzed in vivo the roles of the two subunits of U2AF in the selection between alternative 3' splice sites associated with polypyrimidine tracts of different strengths. Our results reveal a feedback mechanism by which RNA interference (RNAi)-mediated depletion of U2AF(65) triggers the downregulation of U2AF(35). We further show that the knockdown of each U2AF subunit inhibits weak 3' splice site recognition, while overexpression of U2AF(65) alone is sufficient to activate the selection of this splice site. A variant of U2AF(65) lacking the interaction domain with U2AF(35) shows a reduced ability to promote this splicing event, suggesting that recognition of the weak 3' splice site involves the U2AF heterodimer. Furthermore, our data suggest that, rather than being required for splicing of all pre-mRNA substrates containing a weak polypyrimidine tract, U2AF(35) regulates the selection of weak 3' splice sites in a specific subset of cellular transcripts.
引用
收藏
页码:8183 / 8190
页数:8
相关论文
共 41 条
[1]   Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene [J].
Aznarez, I ;
Chan, EM ;
Zielenski, J ;
Blencowe, BJ ;
Tsui, LC .
HUMAN MOLECULAR GENETICS, 2003, 12 (16) :2031-2040
[2]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[3]   FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35 [J].
Chusainow, J ;
Ajuh, PM ;
Trinkle-Mulcahy, L ;
Sleeman, JE ;
Ellenberg, A ;
Lamond, AI .
RNA, 2005, 11 (08) :1201-1214
[4]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[5]   RNA interference is mediated by 21-and 22-nucleotide RNAs [J].
Elbashir, SM ;
Lendeckel, W ;
Tuschl, T .
GENES & DEVELOPMENT, 2001, 15 (02) :188-200
[6]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[7]   Nucleocytoplasmic shuttling of heterodimeric splicing factor U2AF [J].
Gama-Carvalho, M ;
Carvalho, MP ;
Kehlenbach, A ;
Valcárcel, J ;
Carmo-Fonseca, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :13104-13112
[8]   Targeting of U2AF(65) to sites of active splicing in the nucleus [J].
GamaCarvalho, M ;
Krauss, RD ;
Chiang, LJ ;
Valcarcel, J ;
Green, MR ;
CarmoFonseca, M .
JOURNAL OF CELL BIOLOGY, 1997, 137 (05) :975-987
[9]   The role of U2AF35 and U2AF65 in enhancer-dependent splicing [J].
Graveley, BR ;
Hertel, KJ ;
Maniatis, T .
RNA, 2001, 7 (06) :806-818
[10]   Sorting out the complexity of SR protein functions [J].
Graveley, BR .
RNA, 2000, 6 (09) :1197-1211